Hepatocellular carcinoma in elderly patients: challenges and solutions

Por Brunot A, Le Sourd S, Pracht M, Edeline J
Publicado em 2016-06-01

Transarterial Radioembolization (TARE) Agents beyond (90)Y-Microspheres

Por Bouvry, C., Palard, X., Edeline, J., Ardisson, V., Loyer, P., Garin, E., Lepareur, N.
Publicado no Biomed Res Int (2018)

Lobar Hepatocellular Carcinoma with Ipsilateral Portal Vein Tumor Thrombosis Treated with Yttrium-90 Glass Microsphere Radioembolization: Preliminary Results

Por Pracht, M., Edeline, J., Lenoir, L., Latournerie, M., Mesbah, H., Audrain, O., Rolland, Y., Clément, B., Raoul, J. L., Garin, E., Boucher, E.
Publicado em 2013

Angiotensin-2 receptors (AT1-R and AT2-R), new prognostic factors for renal clear-cell carcinoma?

Por Dolley-Hitze, T, Jouan, F, Martin, B, Mottier, S, Edeline, J, Moranne, O, Le Pogamp, P, Belaud-Rotureau, M-A, Patard, J-J, Rioux-Leclercq, N, Vigneau, C
Publicado em 2010

Boosted selective internal radiation therapy with (90)Y-loaded glass microspheres (B-SIRT) for hepatocellular carcinoma patients: a new personalized promising concept

Por Garin, E., Lenoir, L., Edeline, J., Laffont, S., Mesbah, H., Porée, P., Sulpice, L., Boudjema, K., Mesbah, M., Guillygomarc’h, A., Quehen, E., Pracht, M., Raoul, J. L., Clement, B., Rolland, Y., Boucher, E.
Publicado em 2013